AMGN has been in the news 692% more than usual
Feb 06, 2026, 1:32 PM
0.42%
What does AMGN do
Amgen, headquartered in Thousand Oaks, California, is a biotechnology company employing 26,700 staff, focusing on developing human therapeutics for high unmet medical needs. Its product portfolio includes Aranesp, ENBREL, and Prolia, among others.
AMGN has been in the news recently: Markets fell (S&P 500 -1%, Nasdaq -2%) with big stock swings: AMD plunged over 16% while Eli Lilly, a pharma peer of Amgen, rose nearly 10%.
The report did not mention Amgen specifically, but the broad market weakness and sharp individual moves illustrate risks and potential impacts for biopharma peers like Amgen.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.